20.02.2017 07:15:41
|
DGAP-News: AEVIS VICTORIA SA veröffentlicht Angebotsprospekt im Rahmen des öffentlichen Übernahmeangebots für LifeWatch AG
AEVIS VICTORIA SA veröffentlicht Angebotsprospekt im Rahmen des öffentlichen Übernahmeangebots für LifeWatch AG
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Schlagwort(e): Übernahmeangebot
AEVIS VICTORIA SA veröffentlicht Angebotsprospekt im Rahmen des öffentlichen
Übernahmeangebots für LifeWatch AG
20.02.2017 / 07:15 CET/CEST
Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR
---------------------------------------------------------------------------
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND
JAPAN
Pressemitteilung
Freiburg, 20. Februar 2017
AEVIS VICTORIA SA veröffentlicht Angebotsprospekt im Rahmen des
öffentlichen Übernahmeangebots für LifeWatch AG
Das Tauschangebot bewertet eine LifeWatch-Aktie zwischen CHF 12.40 und CHF
13.60
AEVIS VICTORIA SA (AEVIS) hat heute den Angebotsprospekt im Rahmen des
öffentlichen Übernahmeangebots für alle sich im Publikum befindenden
Namenaktien der LifeWatch AG publiziert. Die Voranmeldung wurde am 24.
Januar 2017 veröffentlicht.
Da die AEVIS-Aktien heute nicht als liquide im Sinne des Übernahmerechts
gelten, wurde Ernst & Young beauftragt, eine unabhängige Bewertung der
AEVIS-Aktie zu erstellen. Ernst & Young bewertet eine AEVIS-Aktie zwischen
CHF 68.20 und CHF 74.80. Damit wird eine LifeWatch-Aktie im Rahmen des
Tauschangebots mit CHF 12.40 bis CHF 13.60 bewertet.
AEVIS und ihre Referenzaktionäre halten heute bereits 2'216'267 Namenaktien
von LifeWatch, entsprechend 11.99% des Aktienkapitals und der Stimmrechte.
Das öffentliche Übernahmeangebot unterliegt verschiedenen Bedingungen
inklusive derjenigen, dass AEVIS nach Ablauf der Angebotsfrist mindestens
67% aller ausstehenden Namenaktien von LifeWatch hält. Nach erfolgreichem
Abschluss des Angebots würde LifeWatch als eigenständig geführtes
Tochterunternehmen in AEVIS integriert und es AEVIS so ermöglichen, ihre
Telemedizin-Aktivitäten nachhaltig zu stärken. AEVIS beabsichtigt, die
Wachstumsstrategie von LifeWatch konsequent fortzusetzen. Zudem ist AEVIS
überzeugt, dass LifeWatch von einem starken Ankeraktionär mit breiter
Präsenz im Gesundheitssektor profitieren wird. AEVIS würde in der Lage
sein, eine langfristige Vision und die erforderlichen finanziellen Mittel
zur Weiterentwicklung des Geschäftsmodells einzubringen.
Die Angebotsfrist beginnt am 7. März 2017 und endet am 10. April 2017 um
16:00 Uhr MESZ. Die UBS AG wurde von AEVIS mit der Durchführung des
Übernahmeangebots beauftragt.
Als Teil des öffentlichen Übernahmeangebots wird AEVIS die Jahresresultate
2016 am 27. März 2017 publizieren.
Bezug der Angebotsunterlagen:
Der Angebotsprospekt kann bei UBS AG, Prospectus Library, Postfach, 8098
Zürich Tel. +41 44 239 47 03, Fax +41 44 239 69 14, Email swiss-
prospectus@ubs.com bestellt werden.
Die Dokumentation kann ebenfalls über den nachstehenden Link bezogen
werden:
http://www.aevis.com/websites/aevis/German/3700/uebrige-informationen.html
Für weitere Informationen:
AEVIS VICTORIA SA Medienstelle und Investor Relations:
c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch,
+41 (0) 43 268 32 35 oder +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 26 350 02 02
AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA investiert im Healthcare-Bereich, in Life Sciences sowie
in die medizinische Betreuung und in Lifestyle-Dienstleistungen. Die
Beteiligungen von AEVIS VICTORIA bestehen aus der zweitgrössten
Privatklinikgruppe der Schweiz, Swiss Medical Network, aus Victoria-
Jungfrau Collection, einer Luxushotelgruppe bestehend aus vier Häusern, aus
der Swiss Healthcare Properties AG, eine auf Gesundheitsimmobilien
fokussierte Gesellschaft, aus Medgate, dem führenden Telemedizinanbieter in
der Schweiz und aus NESCENS SA, einer Marke rund um das Thema better-aging.
AEVIS VICTORIA ist an der SIX Swiss Exchange im Swiss Reporting Standard
unter dem Kürzel AEVS.SW kotiert (www.aevis.com).
RESTRICTIONS TO THE OFFER
General
The offer described in this press release is not made directly or
indirectly in any country or jurisdiction in which such offer would be
considered unlawful or in which it would otherwise violate any applicable
law or regulation, or which would require the offeror to amend the terms or
conditions of the offer in any way, or which would require the offeror to
make any additional filing with or take any additional action with regard
to any governmental, regulatory or legal authority. The offeror does not
intend to extend the offer to any such country or jurisdiction. Documents
relating to the offer may not be distributed in such countries or
jurisdictions or sent into such countries or jurisdictions and may not be
used for purposes of soliciting the purchase of any securities of LifeWatch
by any person or entity resident or incorporated in such countries or
jurisdictions.
United States of America
The public tender offer described in this press release is not made
directly or indirectly in or by use of the mail of, or by any means or
instrumentality of interstate or foreign commerce of, or any facilities of
a national securities exchange of, the United States of America and may
only be accepted outside the United States of America. This includes, but
is not limited to, facsimile transmission, telex or telephones. This press
release and any offering materials with respect to the public tender offer
described in this press release may not be distributed in nor sent to the
United States of America and may not be used for the purpose of soliciting
the sale or purchase of any securities of LifeWatch from anyone in the
United States of America. The offeror will not be soliciting the tender of
securities of LifeWatch by any holder of such securities in the United
States of America. Securities of LifeWatch will not be accepted from
holders of such securities in the United States of America. Any purported
acceptance of the offer that the offeror or its agents believe has been
made in or from the United States of America will be invalidated. The
offeror reserves the absolute right to reject any and all acceptances
determined by them not to be in the proper form or the acceptance of which
may be unlawful.
The securities to be issued pursuant to the public tender offer described
in this press release have not been and will not be registered under the
U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), nor
under any law of any state of the United States of America, and may not be
offered, sold, resold, or delivered, directly or indirectly, in or into the
United States of America, except pursuant to an exemption from the
registration requirements of the U.S. Securities Act and the applicable
state securities laws. Neither this press release nor the public tender
offer described in this press release does constitute an offer to sell or
the solicitation of an offer to buy any securities in the United States of
America or in any other jurisdiction in which such an offer or solicitation
would be unlawful. Securities may not be offered or sold in the United
States of America absent registration or an exemption from registration.
AEVIS will not register or make a public offer of its securities, or
otherwise conduct the public tender offer, in the United States of America.
United Kingdom
This communication is directed only at persons in the U.K. who (i) have
professional experience in matters relating to investments, (ii) are
persons falling within article 49(2)(a) to (d) ("high net worth companies,
unincorporated associations, etc") of The Financial Services and Markets
Act 2000 (Financial Promotion) Order 2005 or (iii) to whom it may otherwise
lawfully be communicated (all such persons together being referred to as
"relevant persons"). This communication must not be acted on or relied on
by persons who are not relevant persons. Any investment or investment
activity to which this communication relates is available only to relevant
persons and will be engaged in only with relevant persons.
Australia, Canada, Japan
The public tender offer described in this press release is not addressed to
shareholders of LifeWatch whose place of residence, seat or habitual abode
is in Australia, Canada or Japan, and such shareholders may not accept the
offer.
European Economic Area
The public tender offer described in this press release (the "Offer") is
only being made within the European Economic Area ("EEA") pursuant to an
exemption under Directive 2003/71/EC (as amended and together with any
applicable adopting or amending measures in any relevant member state (as
defined below), the "Prospectus Directive"), as implemented in each member
state of the EEA (each a "relevant member state"), from the requirement to
publish a prospectus that has been approved by the competent authority in
that relevant member state and published in accordance with the Prospectus
Directive as implemented in that relevant member state or, where
appropriate, approved in another relevant member state and notified to the
competent authority in that relevant member state, all in accordance with
the Prospectus Directive. Accordingly, in the EEA, the Offer and documents
or other materials in relation to the offer and the shares in AEVIS (the
"Offeror Shares") are only addressed to, and are only directed at, (i)
qualified investors ("qualified investors") in the relevant member state
within the meaning of Article 2(1)(e) of the Prospectus Directive, as
adopted in the relevant member state, and (ii) persons who hold, and will
tender, the equivalent of at least EUR 100,000 worth of shares in LifeWatch
(the "Target Shares") in exchange for the receipt of offeror Shares
(collectively, "permitted participants"). This press release and the
documents and other materials in relation to the offer may not be acted or
relied upon by persons in the EEA who are not permitted participants, and
each shareholder of LifeWatch seeking to participate in the offer that is
resident in the EEA will be deemed to have represented and agreed that it
is a qualified investor or that it is tendering the equivalent of EUR
100,000 worth of Target Shares in exchange of offeror Shares.
---------------------------------------------------------------------------
Ende der Ad-hoc-Mitteilung
---------------------------------------------------------------------------
545683 20.02.2017 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AEVIS Holding S.A.mehr Nachrichten
Keine Nachrichten verfügbar. |